94 results
6-K
EX-99.1
PRE
Prenetics Global Limited - Ordinary Shares
18 Jun 24
Prenetics Announces First Quarter 2024 Financial Results
8:32am
tax assets
Deferred expenses
Other non-current assets
Non-current assets
Deferred expenses
Inventories
Trade receivables
Deposits, prepayments …
Short-term deposits
Cash and cash equivalents
Current assets
Total assets
Liabilities
Deferred tax liabilities
Warrant liabilities
Lease liabilities
6-K
EX-99.1
PRE
Prenetics Global Limited - Ordinary Shares
1 Apr 24
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
7:38am
-accounted investees
Financial assets at fair value through profit or loss
Deferred tax assets
Deferred expenses
Other non-current assets
Non-current assets …
Liabilities
Deferred tax liabilities
Warrant liabilities
Lease liabilities
Other non-current liabilities
Non-current liabilities
Trade payables
Accrued
424B3
PRE
Prenetics Global Limited - Ordinary Shares
16 Feb 24
Prospectus supplement
6:13am
and regulations, commercial disputes, tax liabilities and other liabilities.
Our post-closing recourse is limited under the ACT Sale and Purchase … and subsidiaries; (viii) management of tax consequences and compliance; and (ix) other challenges caused by distance, language, and cultural differences, making
F-3
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
and other litigation or disputes, information security vulnerabilities, violations of laws, policies, rules and regulations, commercial disputes, tax … , infrastructure and legal compliance costs associated with multiple international locations and subsidiaries; (viii) management of tax consequences
F-3
EX-3.1
PRE
Prenetics Global Limited - Ordinary Shares
17 Jan 24
Shelf registration (foreign)
6:59am
particular circumstances, including tax issues. DISCUSSION WITH MANAGEMENT To facilitate shareholder engagement in the Company, the Annual Meeting
6-K
EX-99.1
5ivo6btjsx1aakvl2stf
20 Nov 23
Prenetics Announces Third Quarter 2023 Financial Results
6:30am
424B3
qqsno25x8amqx50d
2 Nov 23
Prospectus supplement
4:04pm
POS AM
7bo iq8znwq7y82vc
6 Oct 23
Prospectus update (post-effective amendment)
1:52pm
F-3
6lna9jmq152j2 hhl864
29 Sep 23
Shelf registration (foreign)
9:17am
6-K
EX-99.1
qjqj0sa6zp10
18 Sep 23
Prenetics Announces Second Quarter 2023 Financial Results
9:09am
424B3
e1wg3vvz qxr
21 Jul 23
Prospectus supplement
6:16am
CORRESP
te9zk
14 Jul 23
Correspondence with SEC
12:00am
POS AM
kbwarkfje5ighoyf
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
POS AM
EX-10.23
5xhhsutiqg6qe sewu
6 Jul 23
Prospectus update (post-effective amendment)
9:00am
UPLOAD
q1e43fp
14 Jun 23
Letter from SEC
12:00am
6-K
EX-99.1
m4memwfnue
5 Jun 23
Prenetics Announces First Quarter 2023 Financial Results
7:18am
POS AM
wd4m5sexx
31 May 23
Prospectus update (post-effective amendment)
8:25am
CORRESP
9hqzz1p
31 May 23
Correspondence with SEC
12:00am
UPLOAD
qna gp4dvqy18jfxvs
11 May 23
Letter from SEC
12:00am
POS AM
09szk9at4n 650
1 May 23
Prospectus update (post-effective amendment)
5:19pm